MET and gastric cancer: Mechanistically, ESM1 is secreted by gastric cancer cells to act with the membrane receptor c-Met on endothelial cells, which subsequently activates the MAPK signaling pathway and promotes the expression of pro-angiogenic factors, thereby promoting angiogenesis and peritoneal metastasis (Figure 7).